In the BioHarmony Drug Report Database

"Preview" Icon

Zanamivir

Relenza, Dectova (zanamivir) is a small molecule pharmaceutical. Zanamivir was first approved as Relenza on 1999-07-26. It is used to treat human influenza in the USA. It has been approved in Europe to treat human influenza.

 

Trade Name

 

Dectova
 

Common Name

 

zanamivir
 

ChEMBL ID

 

CHEMBL222813
 

Indication

 

human influenza
 

Drug Class

 

Antivirals: neuraminidase inhibitors

Image (chem structure or protein)

Zanamivir structure rendering